Jonathan B. Bricker, Ph.D.

FACULTY MEMBER

Jonathan B. Bricker, Ph.D.

Member, Cancer Prevention Program
Public Health Sciences Division, Fred Hutch

Fax: 206.667.5977
Mail Stop: M3-B232

Dr. Jonathan Bricker develops and tests innovative ways to help people change behaviors that affect health, such as smoking. He’s particularly interested in the delivery of interventions via platforms such as the web, smartphone apps and telephone counseling. His team conducts randomized clinical trials that compare the effectiveness of acceptance and commitment therapy, or ACT, with traditional cognitive behavioral therapy for smoking cessation. (ACT encourages people to notice and accept their urges to smoke with the understanding that those urges will subside.) Dr. Bricker plans to expand this ACT approach to treat obesity and alcohol addiction.

Other Appointments & Affiliations

Affiliate Professor, Graduate Faculty
University of Washington, Department of Psychology

Education

University of Washington, 2003, Ph.D. (Clinical Psychology)

University of Washington, 1999, M.S. (Clinical Psychology)

University of California, 1997, B.A. (Psychology & English)

Research Interests

Dr. Bricker’s research focuses on the development and testing of innovative interventions for health behavior change. With over $14 million in NIH research funding, he and his team are conducting randomized clinical trials of acceptance and commitment therapy interventions for smoking cessation. Technology-based platforms of intervention delivery include telephone coaching, websites, and smartphone apps. He is also developing a separate line of research focusing on innovative behavioral approaches to weight loss.

Current Studies

2018-2019
Project Title: Say “Hello” To Your Digital Coach: Development and Pilot Randomized Trial of the First Conversational Agent for Smoking Cessation
Source of Support: NIH/National Cancer Institute
Grant Type: Cancer Consortium Support Grant, from P30 CA 015704-43
Role: Principle Investigator
Goal: The goal of this study is to develop the first conversational agent for smoking cessation and test its preliminary effectiveness in a pilot randomized trial. Twelve-week usability, receptivity, and preliminary cessation results will provide critical and timely pilot data for an NCI R01 large scale RCT.

2018-2020
Project Title: Pilot Randomized Controlled Trial of a Telephone Weight Loss, Nutrition, Exercise Study (WeLNES)
Source of Support: Hutch Award Luncheon
Grant Type: Fred Hutchinson philanthropic funds
Role: Principle Investigator
Goal: The goal of this project is to conduct pilot randomized trial to compare an innovative new Acceptance and Commitment Therapy (ACT) telephone intervention to a standard behavioral treatment (SBT) telephone control for weight loss, nutrition, and exercise in overweight and obese adults wishing to lose weight.

2017-2019
Project Title: Quit2Heal
Source of Support: CVS Health Foundation
Grant Type: CVS philanthropic funds
Role: Principle Investigator
Goal: To create a smartphone-delivered ACT application for smoking cessation tailored to cancer patients, compared against a smartphone-delivered US Clinical Practice Guidelines application in a pilot RCT. Aims include assessing recruitment feasibility, patient engagement, and usability of the new cancer patient app.

2018-2021
Project Title: Brief Acceptance & Commitment Therapy for HIV-infected at-risk Drinkers
Source of Support: NIH/National AA
Grant Type: R34 AA 026246
Role: Co-Investigator (PI: Sarah Woolf-King, PhD)
Goal: The overall objective of this proposal is to develop and pilot test a brief ACT intervention for PLWH who are at-risk drinkers. We hypothesize that skills learned in the resulting intervention will be preliminarily associated with decreased alcohol use, improved ART adherence, and increased acceptance. The specific aims are as follows: Aim 1: Develop a brief ACT intervention for HIV-infected at-risk drinkers (bACT-AU); Aim 2: Conduct a pilot RCT of bACT-AU compared to a standard brief alcohol intervention.

2016-2021
Project Title: Couple Communication in Cancer: a Multi-method Examination
Source of Support: NIH/National Cancer Institute
Grant Type: R01 CA 201179
Role: Co-Investigator (PI: Shelby Langer, PhD)
Goal: This application aims to identify mechanisms by which communicative processes and cancer patient and partner outcomes are linked, testing the predictive value of (1) two separate models (the social-cognitive processing and relationship intimacy models) in explaining psychological and relationship adjustment as they occur on a day-to-day basis and over the course of one year, and (2) a new integrated model combining key components of the two.

2018-2020
Project Title: A Web-Based Tobacco Cessation Treatment for Veterans with Mental Health Disorders
Source of Support: Bedford Veteran’s Association (VA-ORD)
Grant Type: SPiRE/I21
Role: Co-Investigator (PI: Megan Kelly, PhD)
Goal: This project will adapt an existing, effective, and targeted web-based tobacco cessation intervention for Veterans with mental health disorders and optimize this intervention via iterative usability testing. Results from this pilot project will inform the development of a Merit application to conduct a randomized clinical trial of Vet WebQuit vs. Smokefree.gov.

2015-2020
Project Title: Randomized Trial of an Innovative Smartphone Intervention for Smoking Cessation
Source of Support: NIH/National Cancer Institute
Grant Type: R01 CA 192849
Role: Principal Investigator
Goal: To compare the effectiveness of a smartphone-delivered ACT application against a smartphone-delivered US Clinical Practice Guidelines application in a fully powered RCT (N = 1622). Aims include testing cost effectiveness.

2015 to 2020
Project Title: Telephone-Delivered Acceptance Therapy for Smoking Cessation
Source of Support: NIH/National Institute on Drug Abuse
Grant Type: R01 DA 038411
Role: Principal Investigator
Goal: To compare the effectiveness of telephone-delivered ACT against traditional cognitive behavioral therapy for smoking cessation intervention in a fully powered RCT (Target N = 1168).

2015 to 2018
Project Title: Web-Delivered Acceptance & Commitment Therapy for Smokers with Bipolar Disorder
Source of Support: NIH/National Cancer Institute
Grant Type: R34 DA 040119
Role: Co-Investigator (PI: Jaimee Heffner, PhD)
Goal: To develop, usability test, and conduct a pilot randomized trial of an ACT cessation website for smokers with bipolar disorder.

2013 to 2018
Project Title: Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation
Source of Support: NIH/National Cancer Institute
Grant Type: R01 CA 166646
Role: Principal Investigator
Goal: To compare the effectiveness of web-delivered ACT against the NCI’s web-delivered Smokefree.gov smoking cessation intervention in a fully powered RCT (Target N = 2552).

 

SPOTLIGHT

"If you want to be in the service of the public and in the service of preventing cancer, you have to be able to reach millions of people at low cost with effective treatment."

— Dr. Jonathan Bricker

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.